Wanbury Ltd., a leading pharmaceutical company, has successfully transitioned to the Rise with SAP S/4HANA ERP system as of October 3, 2025. The migration from the legacy SAP ECC platform was executed smoothly, following a structured transition plan and scheduled blackout days on October 1 and 2.
Supported by strategic partner Deloitte, this implementation marks a major step in Wanbury’s vision to build an agile, intelligent, and future-ready enterprise platform. The new SAP S/4HANA system will enhance operational efficiency, improve productivity, and ensure seamless process integration across functions. It also provides real-time data visibility to support faster, informed decision-making.
This upgrade establishes a scalable and robust platform for Wanbury’s future growth initiatives, while strengthening compliance and driving greater agility in the rapidly evolving pharmaceutical sector.
With this strategic move, Wanbury Ltd. reinforces its commitment to innovation, operational excellence, and sustainable growth in India’s pharmaceutical industry.
